EU Committee Recommends Approval of 6 New Biosimilars in July 2024 Meeting
JD Supra Law
AUGUST 7, 2024
The Committee for Medicine Products for Human Use (“CHMP”) recommended 14 medicines for European Medicines Agency Approval (“EMA”) approval (“marketing authorization”), during its monthly meeting on July 22-25, 2024. By: Goodwin
Let's personalize your content